Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism
Description
TMEM106B is an endolysosomal transmembrane protein not only associated with multiple neurological disorders including frontotemporal dementia, Alzheimer's disease, and hypomyelinating leukodystrophy but also potentially involved in COVID-19
